Amgen Inc

Insider Reports History

Entity
Company
Location
One Amgen Center Drive, Thousand Oaks, CA
Signature
/s/ Peter H. Griffith, Executive Vice President and Chief Financial Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Amgen Inc:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BeiGene, Ltd. 10%+ Owner American Depositary Shares 18.9M $3.42B $180.50 Sep 10, 2021 Direct
Neumora Therapeutics, Inc. 10%+ Owner Common Stock 35.4M $424M $11.98 Sep 19, 2023 Direct
Vigil Neuroscience, Inc. 10%+ Owner Common Stock 3.21M $12M $3.75 Jan 11, 2022 Direct
Neumora Therapeutics, Inc. 10%+ Owner Series A-2 Preferred Stock 0 Sep 19, 2023 Direct
Neumora Therapeutics, Inc. 10%+ Owner Series B Preferred Stock 0 Sep 19, 2023 Direct
Vigil Neuroscience, Inc. 10%+ Owner Series A Preferred Stock 0 Jan 11, 2022 Direct

Insider Reports Filed by Amgen Inc

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NMRA Neumora Therapeutics, Inc. Sep 19, 2023 4 $30M 4 Sep 19, 2023 10%+ Owner
NMRA Neumora Therapeutics, Inc. Sep 14, 2023 0 $0 3 Sep 14, 2023 10%+ Owner
VIGL Vigil Neuroscience, Inc. Jan 11, 2022 2 $0 4 Jan 11, 2022 10%+ Owner
VIGL Vigil Neuroscience, Inc. Jan 6, 2022 0 $0 3 Jan 6, 2022 10%+ Owner
BGNE BeiGene, Ltd. Sep 10, 2021 1 $50M 4 Sep 13, 2021 10%+ Owner